Screener
Sana Biotechnology SANA CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| INVESTING ACTIVITIES: | ||
| Purchases of marketable securities | (5,588) | (1,682) |
| Proceeds from maturities of marketable securities | 55,065 | 18,168 |
| Purchases of property and equipment | (288) | (136) |
| Proceeds from disposal of assets | 248 | 253 |
| Net cash provided by investing activities | 49,437 | 16,603 |
| FINANCING ACTIVITIES: | ||
| Proceeds from employee stock purchase plan and exercise of stock options | 59 | 1,127 |
Item 1. Financial Statements
FAQ
- What is Sana Biotechnology's capex?
- Sana Biotechnology (SANA) reported capex of $288K in Q1 2026.
- How has Sana Biotechnology's capex changed year-over-year?
- Sana Biotechnology's capex increased by 111.8% year-over-year, from $136K to $288K.
- What is the long-term trend for Sana Biotechnology's capex?
- Over 3 years (2021 to 2024), Sana Biotechnology's capex has grown at a 3.8% compound annual growth rate (CAGR), from $29.86M to $33.43M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Sana Biotechnology's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude